المؤلفون: Lim SYM; Division of Biomedical Sciences, School of Pharmacy, 69861University of Nottingham Malaysia, Semenyih, Malaysia., Loo JSE; Centre for Drug Discovery and Molecular Pharmacology, Faculty of Health and Medical Sciences, 65214Taylor's University, Selangor, Malaysia., Alshagga M; Division of Biomedical Sciences, School of Pharmacy, 69861University of Nottingham Malaysia, Semenyih, Malaysia., Alshawsh MA; Department of Pharmacology, Faculty of Medicine, 37447Universiti Malaya, Kuala Lumpur, Malaysia., Ong CE; School of Pharmacy, 50103International Medical University, Kuala Lumpur, Malaysia., Pan Y; Division of Biomedical Sciences, School of Pharmacy, 69861University of Nottingham Malaysia, Semenyih, Malaysia.

المصدر: International journal of toxicology [Int J Toxicol] 2022 Sep-Oct; Vol. 41 (5), pp. 355-366. Date of Electronic Publication: 2022 Jun 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Cytochrome P-450 CYP3A*/metabolism , Cytochrome P-450 Enzyme System*/metabolism, Humans ; Ligands ; Microsomes, Liver/metabolism ; Molecular Docking Simulation ; Phenylpropanolamine

المؤلفون: Skryabin VY; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Zastrozhin MS; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia., Grishina EA; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia., Ryzhikova KA; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia., Shipitsyn VV; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., V Barna I; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Galaktionova TE; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Ivanov AV; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Sorokin AS; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia., Bryun EA; Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare, Moscow, Russia.; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia., Sychev DA; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation, Moscow, Russia.

المصدر: Journal of pharmacy practice [J Pharm Pract] 2022 Aug; Vol. 35 (4), pp. 518-523. Date of Electronic Publication: 2021 Feb 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 8900945 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-1937 (Electronic) Linking ISSN: 08971900 NLM ISO Abbreviation: J Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Alcoholism*/complications , Alcoholism*/drug therapy , Alcoholism*/genetics , Cytochrome P-450 CYP3A*/genetics , Diazepam*/adverse effects , Diazepam*/therapeutic use , Hypnotics and Sedatives*/adverse effects , Hypnotics and Sedatives*/therapeutic use , Substance Withdrawal Syndrome*/diagnosis , Substance Withdrawal Syndrome*/drug therapy , Substance Withdrawal Syndrome*/etiology , Substance Withdrawal Syndrome*/genetics, Humans ; Hydrocortisone/therapeutic use ; Male ; Polymorphism, Genetic

المؤلفون: Torres-Zárate C; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría, Mexico City, Mexico., Vences-Mejía A; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría, Mexico City, Mexico., Espinosa-Aguirre JJ; Instituto de Investigaciones Biomédicas, Universidad Autónoma de México, Mexico City, Mexico., Díaz-Díaz E; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría, Mexico City, Mexico., Palacios-Acosta JM; Servicio de Cirugía Oncológica, Instituto Nacional de Pediatría, Mexico City, Mexico., Cárdenas-Cardós R; Servicio de Oncología Médica, Instituto Nacional de Pediatría, Mexico City, Mexico., Hernández-Arrazola D; Servicio de Cirugía Oncológica, Instituto Nacional de Pediatría, Mexico City, Mexico., Shalkow-Klincovstein J; Servicio de Cirugía Oncológica, Instituto Nacional de Pediatría, Mexico City, Mexico., Jurado RR; Departamento de Anatomía Patológica, Instituto Nacional de Pediatría, Mexico City, Mexico., Santes-Palacios R; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría, Mexico City, Mexico., Molina-Ortiz D; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría, Mexico City, Mexico.

المصدر: International journal of toxicology [Int J Toxicol] 2022 May-Jun; Vol. 41 (3), pp. 234-242. Date of Electronic Publication: 2022 Apr 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Cytochrome P-450 CYP3A*/genetics , Sarcoma*/drug therapy , Sarcoma*/genetics , Sarcoma*/pathology, Carcinogenesis ; Child ; Cytochrome P-450 CYP2E1/metabolism ; Cytochrome P-450 Enzyme System/genetics ; Cytochrome P-450 Enzyme System/metabolism ; Humans

المؤلفون: Song HY; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China., Xia JS; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China., Chen YG; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China., Chen L; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China.

المصدر: Human & experimental toxicology [Hum Exp Toxicol] 2022 Jan-Dec; Vol. 41, pp. 9603271221080236.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9004560 Publication Model: Print Cited Medium: Internet ISSN: 1477-0903 (Electronic) Linking ISSN: 09603271 NLM ISO Abbreviation: Hum Exp Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Antineoplastic Agents/*toxicity , Carcinoma, Hepatocellular/*drug therapy , Cytochrome P-450 CYP3A/*genetics , Liver Neoplasms/*drug therapy , Sorafenib/*therapeutic use , Sorafenib/*toxicity, Antineoplastic Agents/metabolism ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Polymorphism, Genetic ; Sorafenib/metabolism ; Tumor Cells, Cultured

المؤلفون: Song HY; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China., Xia JS; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China., Chen YG; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China., Chen L; Department of Pharmacy, 12390Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China.

المصدر: Human & experimental toxicology [Hum Exp Toxicol] 2021 Dec; Vol. 40 (12_suppl), pp. S646-S653. Date of Electronic Publication: 2021 Nov 16.

نوع المنشور: Journal Article; Retracted Publication

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9004560 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0903 (Electronic) Linking ISSN: 09603271 NLM ISO Abbreviation: Hum Exp Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Polymorphism, Genetic*, Antineoplastic Agents/*therapeutic use , Carcinoma, Hepatocellular/*drug therapy , Cytochrome P-450 CYP3A/*genetics , Liver Neoplasms/*drug therapy , Sorafenib/*therapeutic use, Antineoplastic Agents/pharmacokinetics ; Humans ; Sorafenib/pharmacokinetics

المؤلفون: Shin DS; 1 Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, South Korea., Seo H; 1 Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, South Korea., Yang JY; 1 Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, South Korea., Joo J; 1 Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, South Korea., Im SH; 1 Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, South Korea., Kim SS; 1 Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, South Korea., Kim SK; 2 College of Pharmacy, Chungnam National University, Yuseong-gu, Daejeon, South Korea., Bae MA; 1 Bio & Drug Discovery Division, Korea Research Institute of Chemical Technology, Yuseong-gu, Daejeon, South Korea.; 3 Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Yuseong-gu, Daejeon, South Korea.

المصدر: International journal of toxicology [Int J Toxicol] 2018 Sep/Oct; Vol. 37 (5), pp. 393-403. Date of Electronic Publication: 2018 Jun 20.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Chemical and Drug Induced Liver Injury*, Cytochrome P-450 CYP3A/*metabolism , Cytochrome P-450 CYP3A Inhibitors/*pharmacology , Spheroids, Cellular/*drug effects, Cell Culture Techniques ; Cell Survival/drug effects ; Cytochrome P-450 CYP3A/genetics ; Hep G2 Cells ; Humans

المؤلفون: Ma SL; 1 Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, China., Tang NLS; 2 Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, China.; 3 Functional Genomics and Biostatistical Computing Laboratory, Shenzhen Research Institute, The Chinese University of Hong Kong, Hong Kong, China.; 4 Laboratory of Genetics of Disease Susceptibility, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China., Wat KHY; 5 Kwai Chung Hospital, Hong Kong, China., Tang JHY; 5 Kwai Chung Hospital, Hong Kong, China., Lau KH; 6 Queen Mary Hospital, Hong Kong, China., Law CB; 7 Princess Margaret Hospital, Hong Kong, China., Chiu J; 7 Princess Margaret Hospital, Hong Kong, China., Tam CCW; 8 North District Hospital, Hong Kong, China., Poon TK; 9 Kowloon Hospital, Hong Kong, China., Lin KL; 10 Ruttonjee Hospital and Tang Shiu Kin Hospital, Hong Kong, China., Kng CPL; 10 Ruttonjee Hospital and Tang Shiu Kin Hospital, Hong Kong, China., Kong HL; 10 Ruttonjee Hospital and Tang Shiu Kin Hospital, Hong Kong, China., Chan TY; 11 Kwong Wah Hospital, Hong Kong, China., Chan WC; 6 Queen Mary Hospital, Hong Kong, China., Lam LCW; 1 Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, China.

المصدر: American journal of Alzheimer's disease and other dementias [Am J Alzheimers Dis Other Demen] 2019 Aug; Vol. 34 (5), pp. 302-307. Date of Electronic Publication: 2019 May 07.

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 101082834 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-2731 (Electronic) Linking ISSN: 15333175 NLM ISO Abbreviation: Am J Alzheimers Dis Other Demen Subsets: MEDLINE

مواضيع طبية MeSH: Pharmacogenetics*, Alzheimer Disease/*drug therapy , Cholinesterase Inhibitors/*pharmacology , Cytochrome P-450 CYP2D6/*genetics , Cytochrome P-450 CYP3A/*genetics , Donepezil/*pharmacology, Aged ; Aged, 80 and over ; Cholinesterase Inhibitors/adverse effects ; Cytochrome P-450 CYP2C9/genetics ; Donepezil/adverse effects ; Female ; Follow-Up Studies ; Galantamine/pharmacology ; Genotype ; Hong Kong ; Humans ; Male ; Pharmacogenomic Testing ; Rivastigmine/pharmacology

المؤلفون: Nosti-Palacios R; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría (INP), CP 04530, DF, México., Gómez-Garduño J; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría (INP), CP 04530, DF, México., Molina-Ortiz D; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría (INP), CP 04530, DF, México., Calzada-León R; Servicio de Endocrinología, INP, Mexico., Dorado-González VM; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría (INP), CP 04530, DF, México., Vences-Mejía A; Laboratorio de Toxicología Genética, Instituto Nacional de Pediatría (INP), CP 04530, DF, México aritaven@yahoo.com.mx.

المصدر: International journal of toxicology [Int J Toxicol] 2014 Jul; Vol. 33 (4), pp. 325-331. Date of Electronic Publication: 2014 Jul 17.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 9708436 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1092-874X (Electronic) Linking ISSN: 10915818 NLM ISO Abbreviation: Int J Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Aspartame/*therapeutic use , Cerebellum/*enzymology , Cerebrum/*enzymology , Cytochrome P-450 CYP2E1/*metabolism , Cytochrome P-450 CYP3A/*metabolism , Diabetes Mellitus, Type 1/*diet therapy , Non-Nutritive Sweeteners/*therapeutic use, Animals ; Aspartame/adverse effects ; Cerebellum/drug effects ; Cerebrum/drug effects ; Combined Modality Therapy/adverse effects ; Cytochrome P-450 CYP2E1/chemistry ; Cytochrome P-450 CYP2E1 Inducers/adverse effects ; Cytochrome P-450 CYP2E1 Inducers/therapeutic use ; Cytochrome P-450 CYP3A/chemistry ; Cytochrome P-450 CYP3A Inducers/adverse effects ; Cytochrome P-450 CYP3A Inducers/therapeutic use ; Diabetes Mellitus, Type 1/blood ; Diabetes Mellitus, Type 1/drug therapy ; Diabetes Mellitus, Type 1/metabolism ; Enzyme Induction/drug effects ; Hyperglycemia/prevention & control ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/therapeutic use ; Insulin/adverse effects ; Insulin/therapeutic use ; Liver/drug effects ; Liver/enzymology ; Male ; Nerve Tissue Proteins/agonists ; Nerve Tissue Proteins/metabolism ; Neurons/drug effects ; Neurons/enzymology ; Non-Nutritive Sweeteners/adverse effects ; Organ Specificity ; Random Allocation ; Rats, Wistar

المؤلفون: Geist M; 1 Department of Anesthesiology, Center for Pain Therapy and Palliative Care Medicine, Heidelberg University Hospital, Heidelberg, Germany., Bardenheuer H; 1 Department of Anesthesiology, Center for Pain Therapy and Palliative Care Medicine, Heidelberg University Hospital, Heidelberg, Germany., Burhenne J; 2 Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany., Mikus G; 2 Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Heidelberg, Germany.

المصدر: Palliative medicine [Palliat Med] 2019 Jul; Vol. 33 (7), pp. 850-855. Date of Electronic Publication: 2019 Apr 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 8704926 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-030X (Electronic) Linking ISSN: 02692163 NLM ISO Abbreviation: Palliat Med Subsets: MEDLINE

مواضيع طبية MeSH: Palliative Care* , Terminal Care*, Cytochrome P-450 CYP3A/*administration & dosage , Cytochrome P-450 CYP3A/*metabolism, Adult ; Aged ; Aged, 80 and over ; Drug Interactions ; Female ; Humans ; Liver/enzymology ; Male ; Midazolam/administration & dosage ; Midazolam/blood ; Midazolam/pharmacokinetics ; Middle Aged ; Prospective Studies ; Young Adult

المؤلفون: Patel ND; 1 Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA., Chakrabory K; 2 Division of Hematology/Oncology, Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA., Messmer G; 3 Owensboro Health, Owensboro, KY, USA., Krishnan K; 2 Division of Hematology/Oncology, Department of Internal Medicine, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA., Bossaer JB; 4 Department of Pharmacy Practice, Gatton College of Pharmacy, East Tennessee State University, Johnson City, TN, USA.

المصدر: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2018 Dec; Vol. 24 (8), pp. 623-626. Date of Electronic Publication: 2017 Aug 07.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Cytochrome P-450 CYP3A/*genetics , Neutropenia/*chemically induced , Neutropenia/*genetics , Sunitinib/*adverse effects, Carcinoma, Renal Cell/diagnostic imaging ; Carcinoma, Renal Cell/drug therapy ; Carcinoma, Renal Cell/genetics ; Female ; Humans ; Kidney Neoplasms/diagnostic imaging ; Kidney Neoplasms/drug therapy ; Kidney Neoplasms/genetics ; Middle Aged ; Severity of Illness Index